ClinicalTrials.gov record
Completed No phase listed Observational

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

ClinicalTrials.gov ID: NCT00186940

Public ClinicalTrials.gov record NCT00186940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies

Study identification

NCT ID
NCT00186940
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
St. Jude Children's Research Hospital
Other
Enrollment
16 participants

Conditions and interventions

Interventions

  • Rasburicase Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Jan 31, 2010
Completion
Jan 31, 2010
Last update posted
Apr 24, 2017

2005 – 2010

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Stanford University Palo Alto California 94304
Rady Children's Hospital San Diego California 92123
Peyton Manning Children's Hospital at St. Vincent Indianapolis Indiana 46260
Dana-Farber Cancer Institute Boston Massachusetts 02115-6084
Children's Hospital Michigan Detroit Michigan 48201
Columbia University Medical Center New York New York 10032
Rhode Island Hospital Providence Rhode Island 02903
St.Jude Children's Research Hospital Memphis Tennessee 38105
Cook Children's Medical Center Fort Worth Texas 76104
MD Anderson Cancer Center Houston Texas 77030
Mid-West Children's Cancer Center Milwaukee Wisconsin 53226-4801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00186940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2017 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00186940 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →